肿瘤细胞治疗研究
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov、CDE 与 ChiCTR 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
mRNA-Engineered CD5-CAR-γδT(CD5-) Cells for the Immunotherapy of T-Cell Acute Lymphoblastic Leukemia.
Titering of Chimeric Antigen Receptors on CAR T Cells enabled by a Microfluidic-based Dosage-Controlled Intracellular mRNA Delivery Platform.
MEMBER ACCOUNT
登录成功会直接打开下一页。